Creso Pharma Limited (CPH) aims to develop register, and commercialize pharmaceutical-grade cannabis- and hemp-based products and treatments, to the highest GMP quality standards. Company's strategy is to leverage science and research to develop, register and commercialize new cannabis and hemp-derived therapeutic products based on solid scientific data. Company provide safe high grade CBD therapeutic products which are unique in composition, standardized in formulation and dose, and administered by proprietary delivery technologies which fulfill the necessary requirements for efficacy, safety, highest quality and consistency.
Level 1/1 Altona St, West Perth WA 6005, Australia
The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.